An AI algorithm could help to predict which patients might develop significant heart problems years in advance, just based on ...

The algorithm would offer a novel, AI-driven ECG solution capable of detecting moderate-to-severe aortic stenosis. Once cleared by the FDA, the algorithm will be accessible through HeartSciences' ...

Surgery is the default strategy for the treatment of symptomatic patients with bicuspid aortic stenosis, but the US valve guidelines say that TAVI can be considered as an alternative to surgery after ...

HealthDay News — The U.S. Food and Drug Administration has approved the SAPIEN 3 platform, a transcatheter aortic valve replacement (TAVR) therapy, for patients with severe aortic stenosis without ...

Background The comparative outcomes of transcatheter aortic valve replacement (TAVR) in bicuspid versus tricuspid aortic stenosis (AS) with severe calcification remain unclear. This study aimed to ...

FDA approved the Sapien 3 transcatheter aortic valve replacement (TAVR) platform for treatment of severe aortic stenosis early in the disease process while patients still had no symptoms or other ...

“There is an urgent need to change practice and TAVR guidelines for the treatment of aortic stenosis patients, which currently recommend ‘watchful waiting’ until symptoms develop,” said ...

A transcatheter aortic valve replacement platform was approved for severe asymptomatic aortic stenosis. Edwards Lifesciences’ TAVR platform is the first to be approved in this population.

Asymptomatic patients with severe aortic stenosis can now undergo transcatheter aortic valve replacement, thanks to the US Food and Drug Administration’s approval of the new indication for the balloon ...

The following are key points to remember from a review on aortic stenosis (AS), heart failure (HF), and aortic valve replacement (AVR): AS is responsible for the development of HF that is mediated ...

In a trial that many are calling landmark, transcatheter aortic valve replacement had better outcomes than surveillance for patients with severe but asymptomatic aortic stenosis.